Soluble Tumor Necrosis Factor Alpha Receptor 1, Bone Resorption, and Bone Mineral Density in the Year Following Hip Fractures: The Baltimore Hip Studies

Abstract

Although inflammation is known to influence bone turnover and bone mineral density (BMD), less is known about role of soluble tumor necrosis factor alpha receptor 1 (sTNFα-R1) in changes in bone turnover and BMD in the year after hip fracture. We studied 245 persons (117 men and 128 women) from the Baltimore Hip Studies. Bone turnover markers of resorption (carboxy-terminal type I collagen cross-links [CTX-I]) and formation (amino-terminal propeptide type I collagen [P1NP]), BMD of the contralateral hip, and sTNFα-R1 were measured within 15 days of hospitalization and 2, 6, and 12 months later. Latent class growth modeling was used to determine sTNFα-R1 trajectories. Weighted generalized estimating equations were used to examine the association of sTNFα-R1 trajectories with serum levels of CTX-I and P1NP and BMD; standardized beta coefficients (trueβ^) are reported. Higher baseline sTNFα-R1 was significantly associated with a greater rate of CTX-I change (trueβ^ = 0.26, p = 0.004). Four distinct sTNFα-R1 trajectories were identified. The two groups with higher sTNFα-R1 levels during the year following fracture had faster increasing levels of CTX-I compared to the group with lowest sTNFα-R1 levels (men: group 3: trueβ^ = 0.76, p = 0.02; group 4: trueβ^ = 1.4, p < 0.001; women: group 3; trueβ^ = 0.67, p = 0.02; group 4: trueβ^ = 1.3, p = 0.004). Men in the highest sTNFα-R1 group had a greater decline in BMD compared to the lowest sTNFα-R1 group (2-month trueβ^ = −0.01, p = 0.01; 6-month: trueβ^ = −0.09, p = 0.001; 12-months: trueβ^ = −0.1, p < 0.001). An increasing rate of CTX-I was associated with a steeper decline in total hip BMD in those within higher sTNFα-R1 trajectory groups (p < 0.001). CTX-I was significantly increased with sTNFα-R1 in both sexes. CTX-I and the highest sTNFα-R1 trajectory were significantly associated with declines in total hip BMD in men. Interventions that reduce systemic inflammation should be explored to reduce bone resorption and prevent a decline in BMD after hip fracture.

Abnormal changes of bone metabolism markers with age in children with cerebral palsy

“…Studies on different populations (older adults, menopausal females, etc.) reports that bone metabolism changes are closely related to bone density and fractures (7)(8)(9)(10), but this is less studied in children and especially in children with CP. Importantly, low bone mineral density is common in children with CP (8).…”

“…reports that bone metabolism changes are closely related to bone density and fractures (7)(8)(9)(10), but this is less studied in children and especially in children with CP. Importantly, low bone mineral density is common in children with CP (8). Therefore, further investigation is required to determine the attributes of bone metabolism in children with CP.…”